Exploring the pharmacodynamics of multidrug combinations and using the advances in technology to individualise anaesthetic drug titration

In current practice, pharmacokinetic-dynamic (PK/PD) models are frequently used to describe the combined relationship between the time course of drug plasma concentrations (PK) and the time independent relationship between the drug concentration at the receptor site and the clinical effect (PD). This thesis contributes to the knowledge in anaesthetic pharmacology and explores the dose-response relationships of propofol and sevoflurane (with and without the coadministration of remifentanil) in greater detail using PK/PD models. Our studies show that PK/PD models are useful in clinical practice. The concept of neural inertia could have an influence on these models, but is still controversial in humans and it does not break down the essence and applicability of these PK/PD models. Subsequently, we used these models to compare the pharmacodynamics of propofol and sevoflurane (with and without remifentanil) at both a population level as well as at an individual level. This comparison let us describe potency ratios between both hypnotics which is very helpful for anaesthetist when switching between these drugs for any reason during a case. We applied the same PK/PD models and similar potency ratios in clinical practice using the SmartPilot® View, a drug advisory system, to guide anaesthetic drug titration, and we assessed its clinical utility. Finally, we evaluated a novel method to analyse the cerebral drug effect on the EEG using Artificial Intelligence in order to explore the feasibility of whether a single index can quantify the hypnotic effect in a drug-independent way